Genetics and Genomics in 2009

Mutation analysis of the MSMB gene in familial prostate cancer

• Z Kote-Jarai
• D Leongamornlert
• R Eeles

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families

• A M Ray
• K A Zuhlke
• K A Cooney

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

• A Osorio
• R L Milne
• J Benítez

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

• I P M Tomlinson
• M Dunlop
• R S Houlston

Familial association of pancreatic cancer with other malignancies in Swedish families

• E Hiripi
• J Lorenzo Bermejo
• K Hemminki

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells

• D Hong
• W Lu
• X Xie

Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis

• R Fernández-Ramires
• X Solé
• A Osorio

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas

• J M Pita
• A Banito
• V Leite

Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival

• J A M Belien
• T E Buffart
• H I Grabsch

Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease

• K A McAulay
• T Haque
• D H Crawford

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis

• J M Cunningham
• R A Vierkant
• E L Goode

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma

• R J Flockhart
• J L Armstrong
• P E Lovat

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

• O M Sinilnikova
• A C Antoniou
• D Stoppa-Lyonnet

GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

• V Hoene
• M Fischer
• C Dame

MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression

• B Diosdado
• M A van de Wiel
• G A Meijer

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

• F Loupakis
• A Ruzzo
• F Graziano

Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

• K Jacob
• S Albrecht
• N Jabado

Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

• D M Kweekel
• N F Antonini
• H-J Guchelaar

Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia

• N Ban
• M Kai

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

• N Faur
• L Araud
• V Le Morvan